Jun 07, 2021 / 10:00PM GMT
Operator
Thank you for standing by, and welcome to the Coherus and Junshi BioSciences post-ASCO investor event. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions) I would now like to hand the conference over to your host, Chief Financial Officer, McDavid Stilwell. Please go ahead.
McDavid Stilwell - Coherus BioSciences, Inc. - CFO
Thank you. Good afternoon, everyone. And on behalf of Coherus and our immuno-oncology partner, Junshi Biosciences, I want to welcome you to our conference call review toripalimab clinical data presented at ASCO and key elements of the ongoing toripalimab clinical development program.
During the course of this conference call, we will -- we will refer to the slide deck that is posted now on the Events and Presentations page of the Investor Relations section of the Coherus website.
Today's call includes forward-looking statements regarding Coherus' current expectations. These statements include, but are not limited to, our ability to advance toripalimab and other product
Coherus BioSciences Inc and Shanghai Junshi Biosciences Co Ltd Virtual Investor Event to Discuss Toripalimab Clinical Data from the ASCO Annual Meeting Transcript
Jun 08, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers